CRLF2: Potential Drug Target and Biomarker for Various Diseases

Target Name: CRLF2

NCBI ID: G64109

CRLF2

CRLF2: Potential Drug Target and Biomarker for Various Diseases

CRLF2 (Cysteinyl leukemia- associated protein 2) is a protein that is expressed in a variety of tissues, including the brain, spleen, heart, and lymphoid organs. It is a member of the cryptotransmembrane protein (CTP) family, which includes proteins that are involved in various cellular processes, including cell signaling, migration, and invasion.

One of the unique features of CRLF2 is its ability to interact with the protein TSLPR (Tissue Society protein) and form a complex with it. This interaction between CRLF2 and TSLPR is important for the regulation of various cellular processes, including cell signaling, angiogenesis, and inflammation.

CRLF2 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of CRLF2 are associated with poor prognosis in patients with pancreatic cancer, and that CRLF2 is a potential drug target for this disease.

In addition to its potential as a drug target, CRLF2 has also been shown to be a valuable biomarker for several diseases, including pancreatic cancer, lung cancer, and breast cancer. For example, studies have shown that CRLF2 levels are elevated in pancreatic cancer tissue, and that these levels can be used as a diagnostic marker for this disease.

CRLF2 has also been shown to be involved in the regulation of cellular processes that are important for normal brain function. For example, studies have shown that CRLF2 is involved in the regulation of neurotransmitter release from nerve axons, which is important for the proper functioning of the nervous system.

In conclusion, CRLF2 is a protein that has important roles in various cellular processes, including cell signaling, angiogenesis, and inflammation. Its interaction with TSLPR and ability to form a complex with it makes it a potential drug target, and its potential as a biomarker for several diseases makes it an important area of research. Further studies are needed to fully understand the role of CRLF2 in these processes and its potential as a drug and biomarker.

Protein Name: Cytokine Receptor Like Factor 2

Functions: Receptor for thymic stromal lymphopoietin (TSLP). Forms a functional complex with TSLP and IL7R which is capable of stimulating cell proliferation through activation of STAT3 and STAT5. Also activates JAK2 (By similarity). Implicated in the development of the hematopoietic system

The "CRLF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CRLF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets